Surgical Dressing Billing Fraud: The Wound, the Dressing and the Repeat Claim

Surgical dressing billing fraud involves knowingly billing Medicare for dressings that the wound, product or supply records do not support. A supplier can ship a real dressing and still bill for a size it did not send, a wound that does not qualify or a refill the patient never requested. Taxpayers pay for the unsupported claim, and the patient can end up with another box nobody asked for. If you work in billing, wound care or fulfillment, you may see the gap between what the patient needs, what leaves the warehouse and what Medicare pays for.

The evidence connects those parts of the business. The wound record explains eligibility. The product identifies the material and dimensions. The order, delivery record and refill contact explain the quantity and the repeated claims. We work with insiders who know where that account stops matching what happened.

When the Wound Does Not Qualify

Medicare does not cover a surgical dressing claim with no qualifying surgical wound. Medicare’s surgical dressing coverage requires a wound that was surgically created or modified, or debrided.

Compression bandages and multi-layer systems show why this matters. They qualify under the surgical dressing benefit when used as primary or secondary dressings over a qualifying wound. Without that wound, the claim fails before the discussion reaches which dressing was ordered or how much it cost.

For a wound-care employee, the connection is concrete: which wound supports this claim, and where does its qualifying history appear? For a biller, the same question reaches the supporting clinical documentation behind the order.

A whistleblower’s complaint against Hill-Rom illustrates the problem in a different product category, beds and mattresses. The complaint alleged that patients lacked the wound or weight criteria for the products billed:

The allegation puts the clinical record beside the product sold. The equivalent comparison for a surgical dressing starts with its own qualifying-wound requirement. Someone can have a wound, receive a product and still lack the clinical facts required for the claim the supplier submitted.

A6197 Billing for Sixteen to Forty-Eight Square Inches

A6197 billing covers an alginate wound cover in the 16 to 48 square inch size band. That size band describes the dressing supplied. The wound record explains whether the patient qualifies. The product record shows what the supplier sent.

A supplier employee may know the product by its packaging or catalog description while the biller works from a code. We connect those descriptions to the actual dressing. If the claim describes an alginate cover in that size band, the supplied product must support that description. A coding instruction that disregards the product’s dimensions is a concrete place to examine who selected the code and why.

Material matters as much as size. Medicare’s dressing policy recognizes materials such as alginate, collagen and foam. Other materials need sufficient credible clinical evidence for inclusion. A product made from several components is classified by its clinically predominant component.

That last rule reaches the manufacturer’s product description as well as the supplier’s billing file. Adding a small amount of a recognized material to a dressing made predominantly from an unrecognized material does not make the whole product payable. The composition of the pad matters alongside the name on the box.

What Evidence Is Needed to Report Medicare Fraud?

For surgical dressings, the evidence connects the wound record, written order, supplied product, delivery and claim. An insider who knows how those records were created can also explain who chose the code, changed the documentation or directed the repeated billing.

The standard written order identifies the patient, item, quantity, order date and ordering practitioner, and carries the practitioner’s signature. The supplier holds that order and the practitioner’s supporting documentation. Those records give us a clinical and ordering account to compare with what the business shipped and billed.

Proof of delivery supplies another part of the comparison. The supplier is responsible for delivery and for keeping the evidence of it. The Centers for Medicare & Medicaid Services’ standard documentation requirements also prohibit suppliers, their employees and others with a financial interest in delivery from signing and accepting an item on the patient’s behalf. Who accepted the dressing matters alongside what the ticket says was delivered.

The records can sit with different people. A clinician knows the wound. A supplier employee knows the product and shipment. A biller sees the quantity and code submitted for payment. We connect that knowledge to the particular claims and to the instructions inside the business.

Repeated Supplies Need a New Response

Before a refill ships, the supplier must contact the patient or their representative and document that they want it. An original order does not authorize automatic shipments on a predetermined schedule, even when the patient previously agreed to that schedule. The refill request must occur and be documented before shipment.

The contact record and the shipment record should tell the same story about which came first. Medicare does not accept a later statement from the supplier or patient as a substitute for the refill request documented before shipment.

The quantity billed must follow the patient’s wound, the order and the requested refill. We examine the reason for repeated supplies and the records behind each shipment, including whether the business kept sending them on a schedule of its own.

Skin Substitutes Use a Different Payment System

Skin substitutes are biological products paid through the physician fee schedule or hospital outpatient system. Surgical dressings such as alginate wound covers run through Medicare’s durable medical equipment, prosthetics, orthotics and supplies system. The same health care business can sell both, but the product determines which payment rules apply.

These products also go to different Medicare contractors. For surgical dressings, the claim follows the qualifying wound, dressing material, size and supplied quantity.

Negative Pressure Wound Therapy Has Its Own Product Question

Negative pressure wound therapy involves a rented pump and recurring dressing kits and canisters. The pump and the supplies have distinct billing roles. A dressing used with that system belongs in the context of the pump and treatment it supports.

In 2017, Innovative Therapies and its parent, Cardinal Health, agreed to a $2,715,000 civil settlement over allegations involving Innovative Therapies’ negative pressure wound therapy devices. The whistleblower’s complaint alleged that Innovative Therapies marketed certain devices as durable medical equipment while knowing they lacked the expected life the equipment category requires.

The alleged problem was in the product’s claimed eligibility for payment. For a supplier carrying wound-care products, that puts the manufacturer’s representations beside the code used to bill Medicare. The question reaches the sales pitch as well as the claim.

What the Supplier Was Told to Bill

Product marketing can supply evidence of how a billing practice began. In Justice Department testimony published in the 2003 House hearing Waste, Fraud, and Abuse, the department described Operation Headwaters, an undercover investigation of manufacturers selling enteral feeding, diabetic footwear and wound-care products. The FBI posed as a national medical-equipment distributor and recorded dealings with manufacturers’ officers and employees.

The investigation put the sales conversation on tape. For a dressing business, the same connection matters: what the manufacturer said the product was, what it told the supplier to bill and which claims followed. A billing instruction can explain why the same product description keeps appearing on claims.

When a Billing Spike Leads Back to the Claim

When surgical dressing billing rises, the question for an insider is what changed inside the business: the product supplied, the code selected, the patients served or the frequency of shipments. Medicare’s equipment-and-supply data gives the payment side of that comparison. The insider knows how the business produced the claims.

A surgical dressing whistleblower case connects the payment pattern to decisions and records. Who directed the code selection? What wound documentation supported the orders? What did the supplier send, and what contact preceded each refill? We work through those connections with you to identify the conduct behind the claims. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

Bring Us the Gap Between the Wound and the Bill

If you know why the wound record, dressing supplied and Medicare claim tell different stories, speak with our whistleblower experts about the claims you see. We work beside supplier employees, clinicians and billers to build a surgical dressing fraud case around the product, the payments and the people directing the billing. We bring in healthcare fraud whistleblower lawyers who understand medical-supply claims, and we stay with you through the case.